PL1846430T3 - Nowe makrolidy - Google Patents

Nowe makrolidy

Info

Publication number: PL1846430T3
Authority: PL; Poland
Prior art keywords: antibiotics; diseases; human; new macrolides; new
Prior art date: 2005-02-09

Application number

PL06701650T

Other languages

English (en)

Inventor

Johannes Laurenz Kellenberger

Stuart Robert Shapiro

Salima Mathews

Philippe Guerry

Pierre Jacques Noël BARBIER

Original Assignee

Basilea Pharmaceutica Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-02-09

Filing date

2006-02-08

Publication date

2009-08-31

2006-02-08 Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag

2009-08-31 Publication of PL1846430T3 publication Critical patent/PL1846430T3/pl

Links

239000003120 macrolide antibiotic agent Substances 0.000 title abstract 2
229940041033 macrolides Drugs 0.000 title 1
239000003242 anti bacterial agent Substances 0.000 abstract 2
229940088710 antibiotic agent Drugs 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
208000035473 Communicable disease Diseases 0.000 abstract 1
230000001668 ameliorated effect Effects 0.000 abstract 1
230000003115 biocidal effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
208000027866 inflammatory disease Diseases 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Peptides Or Proteins (AREA)
Steroid Compounds (AREA)

PL06701650T 2005-02-09 2006-02-08 Nowe makrolidy PL1846430T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP05002664		2005-02-09
EP05011419		2005-05-26
EP06701650A EP1846430B1 (en)	2005-02-09	2006-02-08	New macrolides
PCT/CH2006/000083 WO2006084410A1 (en)	2005-02-09	2006-02-08	New macrolides

Publications (1)

Publication Number	Publication Date
PL1846430T3 true PL1846430T3 (pl)	2009-08-31

Family

ID=36204543

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL06701650T PL1846430T3 (pl)	2005-02-09	2006-02-08	Nowe makrolidy

Country Status (17)

Country	Link
US (1)	US7524823B2 (pl)
EP (1)	EP1846430B1 (pl)
JP (1)	JP5112079B2 (pl)
KR (1)	KR101139751B1 (pl)
AT (1)	ATE427315T1 (pl)
AU (1)	AU2006212626B2 (pl)
CA (1)	CA2597327C (pl)
CY (1)	CY1109187T1 (pl)
DE (1)	DE602006006030D1 (pl)
DK (1)	DK1846430T3 (pl)
ES (1)	ES2322775T3 (pl)
HR (1)	HRP20090302T1 (pl)
MX (1)	MX2007008549A (pl)
PL (1)	PL1846430T3 (pl)
SI (1)	SI1846430T1 (pl)
TW (1)	TWI389916B (pl)
WO (1)	WO2006084410A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0716408A2 (pt) *	2006-08-09	2013-09-24	Basilea Pharmaceutica Ag	macrolÍdeos éteis doenÇa inflamatària e alÉrgica
CA2661538A1 (en) *	2006-08-24	2008-02-28	Wockhardt Research Centre	Novel macrolides and ketolides having antimicrobial activity
CA2714389C (en) *	2008-02-08	2016-10-18	Basilea Pharmaceutica Ag	Macrolides and uses of macrolides
WO2009106419A1 (en) *	2008-02-08	2009-09-03	Basilea Pharmaceutica Ag	New macrolides and their use
EP2271656A1 (en) *	2008-04-23	2011-01-12	Glaxo Group Limited	2'-o,3'-n-bridged macrolides
ES2561332T3 (es) *	2009-05-27	2016-02-25	Wockhardt Limited	Compuestos cetólidos que tienen actividad antimicrobiana
ES2582794T3 (es)	2009-08-13	2016-09-15	Basilea Pharmaceutica Ag	Nuevos macrólidos y su uso
HUE030196T2 (en) *	2012-12-31	2017-04-28	Basilea Pharmaceutica Ag	Macrolides with PDE4 inhibitory activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4162992B2 (ja)	2000-08-22	2008-10-08	バジリアファルマスーチカアーゲー	抗菌活性を有する新規マクロライド
CA2451391A1 (en) *	2001-07-03	2003-01-16	Chiron Corporation	C12 modified erythromycin macrolides and ketolides having antibacterial activity
JP2005538927A (ja) *	2002-01-17	2005-12-22	コーザンバイオサイエンシスインコーポレイテッド	アミドマクロライド
US6995143B2 (en) *	2002-02-28	2006-02-07	Basilea Pharmaceutica Ag	Macrolides with antibacterial activity
DE102004002638A1 (de)	2004-01-19	2005-08-18	Merck Patent Gmbh	Kombinationen von Serotonin-Wiederaufnahme-Hemmern und Imidazolin-I2-Agonisten

2006
- 2006-02-08 JP JP2007554411A patent/JP5112079B2/ja not_active Expired - Fee Related
- 2006-02-08 DE DE602006006030T patent/DE602006006030D1/de not_active Expired - Lifetime
- 2006-02-08 DK DK06701650T patent/DK1846430T3/da active
- 2006-02-08 AT AT06701650T patent/ATE427315T1/de active
- 2006-02-08 HR HR20090302T patent/HRP20090302T1/xx unknown
- 2006-02-08 ES ES06701650T patent/ES2322775T3/es not_active Expired - Lifetime
- 2006-02-08 TW TW095104242A patent/TWI389916B/zh not_active IP Right Cessation
- 2006-02-08 CA CA2597327A patent/CA2597327C/en not_active Expired - Fee Related
- 2006-02-08 EP EP06701650A patent/EP1846430B1/en not_active Expired - Lifetime
- 2006-02-08 AU AU2006212626A patent/AU2006212626B2/en not_active Ceased
- 2006-02-08 KR KR1020077018855A patent/KR101139751B1/ko not_active Expired - Fee Related
- 2006-02-08 WO PCT/CH2006/000083 patent/WO2006084410A1/en not_active Ceased
- 2006-02-08 SI SI200630285T patent/SI1846430T1/sl unknown
- 2006-02-08 MX MX2007008549A patent/MX2007008549A/es active IP Right Grant
- 2006-02-08 PL PL06701650T patent/PL1846430T3/pl unknown
- 2006-05-08 US US11/429,678 patent/US7524823B2/en not_active Expired - Fee Related
2009
- 2009-06-29 CY CY20091100676T patent/CY1109187T1/el unknown

Also Published As

Publication number	Publication date
TWI389916B (zh)	2013-03-21
TW200640942A (en)	2006-12-01
DE602006006030D1 (de)	2009-05-14
KR101139751B1 (ko)	2012-04-26
SI1846430T1 (sl)	2009-08-31
KR20070113206A (ko)	2007-11-28
US7524823B2 (en)	2009-04-28
JP5112079B2 (ja)	2013-01-09
ATE427315T1 (de)	2009-04-15
DK1846430T3 (da)	2009-06-22
ES2322775T3 (es)	2009-06-26
EP1846430B1 (en)	2009-04-01
EP1846430A1 (en)	2007-10-24
CA2597327C (en)	2012-02-07
JP2008530035A (ja)	2008-08-07
MX2007008549A (es)	2007-08-14
HRP20090302T1 (hr)	2009-07-31
AU2006212626B2 (en)	2010-04-29
AU2006212626A1 (en)	2006-08-17
US20060264387A1 (en)	2006-11-23
CA2597327A1 (en)	2006-08-17
WO2006084410A1 (en)	2006-08-17
CY1109187T1 (el)	2014-07-02

Publication	Publication Date	Title
NZ593111A (en)	2013-05-31	Antibacterial compounds
NZ577916A (en)	2012-11-30	Cyclopamine analogs
MX2009000333A (es)	2009-03-13	Pirrilopirimidinas para composiciones farmaceuticas.
GB0625648D0 (en)	2007-01-31	Compounds
GEP20156309B (en)	2015-07-10	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2008011130A8 (en)	2009-04-16	Amide compounds
MX2009009153A (es)	2009-09-03	Pirano-pirazol-aminas.
IL211120A (en)	2014-09-30	Compound, tetracycline converted at position 7c with fluorine, a pharmaceutical preparation containing it and its use in the preparation of drugs for the treatment of bacteria-caused infection
EP3216798A3 (en)	2017-10-25	Ketolide compounds
MX2009009154A (es)	2009-09-04	Derivados de espiro-pirano-pirazol.
WO2011039735A3 (en)	2011-06-16	Compounds with ddx3 inhibitory activity and uses thereof
MX2011005425A (es)	2011-09-27	Derivados de carboxiamida lantibiotica con actividad antibacteriana mejorada.
NZ596628A (en)	2013-03-28	Ketolide compounds having antimicrobial activity
TW200626608A (en)	2006-08-01	Macrolides
WO2008023248A3 (en)	2009-04-23	Novel macrolides and ketolides having antimicrobial activity
IN2012DN03846A (pl)	2015-08-28
MX2011008074A (es)	2011-08-17	Macrolido anti-inflamatorio.
CY1109187T1 (el)	2014-07-02	Νεα μακρολιδια
IL196469A (en)	2013-09-30	History of triazine and their use in the preparation of drugs for the treatment of diseases
MX2009006325A (es)	2009-07-24	Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
MX2009013482A (es)	2010-01-27	Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas.
WO2009035553A3 (en)	2009-05-07	Analogs of tetramic acid
IL194353A0 (en)	2011-08-01	Lysobactin amides
DE602007007934D1 (en)	2010-09-02	Imidazoazephinonverbindungen
MX2009009074A (es)	2009-09-28	Macrolidos basados en eritromicina.